| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 185,787 | 205,198 | 199,220 | 112,332 | | Cost of Revenue | (11,446) | 95,947 | 69,427 | 60,474 | | | Gross Profit | 197,233 | 109,251 | 129,793 | 51,858 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,072 | 32,036 | 13,979 | 13,614 | | Non Recurring | 63,495 | 12,685 | 159,567 | 325,097 | | Others | 66,958 | 70,391 | 91,712 | 95,403 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 457 | (5,861) | (135,465) | (382,256) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (27,793) | 105 | 22 | 193,630 | | Earnings Before Interest And Taxes | 547 | (5,756) | (135,443) | (188,626) | | Interest Expense | 7,565 | 7,663 | 6,096 | 4,417 | | Income Before Tax | (7,018) | (13,419) | (141,539) | (193,043) | | Income Tax Expense | (2,603) | (5,097) | (53,916) | (67,003) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,415) | (8,322) | (87,623) | (126,040) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,415) | (8,322) | (87,623) | (126,040) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,415) | ($8,322) | ($87,623) | ($126,040) |
|
0.01% Nasdaq 
Income Statement
